| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/21/2022 | 6% | Alliance Global Partners | $11 → $4.5 | Downgrades | Buy → Neutral |
| 07/28/2022 | 111.99% | HC Wainwright & Co. | $8 → $9 | Maintains | Buy |
| 05/10/2022 | 88.44% | HC Wainwright & Co. | $10 → $8 | Maintains | Buy |
| 02/25/2022 | 135.55% | HC Wainwright & Co. | $12 → $10 | Maintains | Buy |
| 08/16/2021 | 182.66% | HC Wainwright & Co. | $16 → $12 | Maintains | Buy |
| 04/15/2021 | 276.88% | HC Wainwright & Co. | $14 → $16 | Maintains | Buy |
| 04/14/2020 | 229.77% | HC Wainwright & Co. | $15 → $14 | Reiterates | → Buy |
| 04/07/2020 | 253.32% | B. Riley Securities | $24 → $15 | Maintains | Buy |
| 11/18/2019 | 253.32% | HC Wainwright & Co. | $1 → $15 | Maintains | Buy |
| 10/31/2019 | -76.45% | HC Wainwright & Co. | $1.5 → $1 | Maintains | Buy |
| 05/28/2019 | -29.34% | Craig-Hallum | → $3 | Initiates Coverage On | → Buy |
| 06/29/2018 | -35.22% | B. Riley Securities | → $2.75 | Initiates Coverage On | → Buy |
What is the target price for Alimera Sciences (ALIM)?
The latest price target for Alimera Sciences (NASDAQ: ALIM) was reported by Alliance Global Partners on November 21, 2022. The analyst firm set a price target for $4.50 expecting ALIM to rise to within 12 months (a possible 6.00% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Alimera Sciences (ALIM)?
The latest analyst rating for Alimera Sciences (NASDAQ: ALIM) was provided by Alliance Global Partners, and Alimera Sciences downgraded their neutral rating.
When is the next analyst rating going to be posted or updated for Alimera Sciences (ALIM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alimera Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alimera Sciences was filed on November 21, 2022 so you should expect the next rating to be made available sometime around November 21, 2023.
Is the Analyst Rating Alimera Sciences (ALIM) correct?
While ratings are subjective and will change, the latest Alimera Sciences (ALIM) rating was a downgraded with a price target of $11.00 to $4.50. The current price Alimera Sciences (ALIM) is trading at is $4.25, which is out of the analyst's predicted range.